DK3494108T3 - Syntese af (s)-2-amino-4-methyl-1-((r)-2-methyloxiran-2-yl)-pentan-1-on og farmaceutisk acceptable salte deraf - Google Patents
Syntese af (s)-2-amino-4-methyl-1-((r)-2-methyloxiran-2-yl)-pentan-1-on og farmaceutisk acceptable salte deraf Download PDFInfo
- Publication number
- DK3494108T3 DK3494108T3 DK17751954.3T DK17751954T DK3494108T3 DK 3494108 T3 DK3494108 T3 DK 3494108T3 DK 17751954 T DK17751954 T DK 17751954T DK 3494108 T3 DK3494108 T3 DK 3494108T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyloxiran
- pentan
- synthesis
- amino
- methyl
- Prior art date
Links
- ASROSKVBCYFAHU-IONNQARKSA-N (2s)-2-amino-4-methyl-1-[(2r)-2-methyloxiran-2-yl]pentan-1-one Chemical compound CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1 ASROSKVBCYFAHU-IONNQARKSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/1616—Coordination complexes, e.g. organometallic complexes, immobilised on an inorganic support, e.g. ship-in-a-bottle type catalysts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
- C07D301/12—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with hydrogen peroxide or inorganic peroxides or peracids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
- B01J2531/72—Manganese
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epoxy Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662371686P | 2016-08-05 | 2016-08-05 | |
| US201762536862P | 2017-07-25 | 2017-07-25 | |
| PCT/US2017/045274 WO2018027021A1 (en) | 2016-08-05 | 2017-08-03 | Synthesis of (s)-2-amino-4-methyl-1-((r)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3494108T3 true DK3494108T3 (da) | 2021-01-11 |
Family
ID=59593230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17751954.3T DK3494108T3 (da) | 2016-08-05 | 2017-08-03 | Syntese af (s)-2-amino-4-methyl-1-((r)-2-methyloxiran-2-yl)-pentan-1-on og farmaceutisk acceptable salte deraf |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US11708341B2 (da) |
| EP (1) | EP3494108B1 (da) |
| JP (1) | JP7229912B2 (da) |
| KR (1) | KR102482663B1 (da) |
| CN (1) | CN109641863B (da) |
| AU (1) | AU2017306546B2 (da) |
| CL (1) | CL2019000294A1 (da) |
| CO (1) | CO2019001139A2 (da) |
| CR (1) | CR20190113A (da) |
| CY (1) | CY1124363T1 (da) |
| DK (1) | DK3494108T3 (da) |
| ES (1) | ES2842575T3 (da) |
| HU (1) | HUE051980T2 (da) |
| IL (1) | IL264549B (da) |
| JO (1) | JOP20190016B1 (da) |
| LT (1) | LT3494108T (da) |
| MX (1) | MX383751B (da) |
| MY (1) | MY204928A (da) |
| PE (1) | PE20190404A1 (da) |
| PH (1) | PH12019500232B1 (da) |
| PL (1) | PL3494108T3 (da) |
| PT (1) | PT3494108T (da) |
| SA (1) | SA519401022B1 (da) |
| SG (2) | SG11201900991UA (da) |
| SI (1) | SI3494108T1 (da) |
| TN (1) | TN2019000028A1 (da) |
| UA (1) | UA125648C2 (da) |
| WO (1) | WO2018027021A1 (da) |
| ZA (1) | ZA201900717B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114195741A (zh) * | 2021-12-28 | 2022-03-18 | 南京格亚医药科技有限公司 | 一种卡非佐米关键中间体异构体的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7232818B2 (en) | 2004-04-15 | 2007-06-19 | Proteolix, Inc. | Compounds for enzyme inhibition |
| US20050256324A1 (en) * | 2004-05-10 | 2005-11-17 | Proteolix, Inc. | Synthesis of amino acid keto-epoxides |
| JP2006028154A (ja) | 2004-06-14 | 2006-02-02 | Sumitomo Chemical Co Ltd | 光学活性化合物の製造方法 |
| ES2549763T3 (es) | 2004-12-07 | 2015-11-02 | Onyx Therapeutics, Inc. | Composición para inhibición del proteasoma |
| RS54847B2 (sr) | 2007-10-04 | 2019-09-30 | Onyx Therapeutics Inc | Inhibitori kristalne peptid epoksi keton proteaze i sinteza aminokiselinskih keto-epoksida |
| JP5675629B2 (ja) | 2008-10-21 | 2015-02-25 | オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | ペプチドエポキシケトンを用いた併用療法 |
| MY165002A (en) | 2012-05-08 | 2018-02-28 | Onyx Therapeutics Inc | Cylodextrin complexation methods for formulating peptide proteasome inhibitors |
| US20140105921A1 (en) | 2012-07-09 | 2014-04-17 | Onyx Therapeutics, Inc. | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors |
| EP2874606B1 (en) | 2012-07-18 | 2019-03-06 | Onyx Therapeutics, Inc. | Liposomal compositions of epoxyketone-based proteasome inhibitors |
| DE102013104003B3 (de) | 2013-04-19 | 2014-03-13 | Glatt Systemtechnik Gmbh | Vorrichtung zum Einbringen einer definierten Menge eines zweiten Pulvers in einen Prozessbehälter |
| CN104230857A (zh) * | 2014-08-19 | 2014-12-24 | 上海皓元生物医药科技有限公司 | 卡非佐米(Carfilzomib)的中间体化合物的制备方法及其中间体化合物 |
-
2017
- 2017-08-03 WO PCT/US2017/045274 patent/WO2018027021A1/en not_active Ceased
- 2017-08-03 SG SG11201900991UA patent/SG11201900991UA/en unknown
- 2017-08-03 HU HUE17751954A patent/HUE051980T2/hu unknown
- 2017-08-03 AU AU2017306546A patent/AU2017306546B2/en active Active
- 2017-08-03 US US16/327,079 patent/US11708341B2/en active Active
- 2017-08-03 UA UAA201902137A patent/UA125648C2/uk unknown
- 2017-08-03 TN TNP/2019/000028A patent/TN2019000028A1/en unknown
- 2017-08-03 ES ES17751954T patent/ES2842575T3/es active Active
- 2017-08-03 JO JOP/2019/0016A patent/JOP20190016B1/ar active
- 2017-08-03 KR KR1020197006357A patent/KR102482663B1/ko active Active
- 2017-08-03 SI SI201730575T patent/SI3494108T1/sl unknown
- 2017-08-03 MY MYPI2019000529A patent/MY204928A/en unknown
- 2017-08-03 DK DK17751954.3T patent/DK3494108T3/da active
- 2017-08-03 JP JP2019506144A patent/JP7229912B2/ja active Active
- 2017-08-03 PT PT177519543T patent/PT3494108T/pt unknown
- 2017-08-03 LT LTEP17751954.3T patent/LT3494108T/lt unknown
- 2017-08-03 SG SG10201912268UA patent/SG10201912268UA/en unknown
- 2017-08-03 MX MX2019001459A patent/MX383751B/es unknown
- 2017-08-03 CR CR20190113A patent/CR20190113A/es unknown
- 2017-08-03 PL PL17751954T patent/PL3494108T3/pl unknown
- 2017-08-03 CN CN201780048527.3A patent/CN109641863B/zh active Active
- 2017-08-03 PE PE2019000337A patent/PE20190404A1/es unknown
- 2017-08-03 PH PH1/2019/500232A patent/PH12019500232B1/en unknown
- 2017-08-03 EP EP17751954.3A patent/EP3494108B1/en active Active
-
2019
- 2019-01-30 IL IL264549A patent/IL264549B/en unknown
- 2019-02-04 ZA ZA2019/00717A patent/ZA201900717B/en unknown
- 2019-02-04 CL CL2019000294A patent/CL2019000294A1/es unknown
- 2019-02-04 SA SA519401022A patent/SA519401022B1/ar unknown
- 2019-02-07 CO CONC2019/0001139A patent/CO2019001139A2/es unknown
-
2021
- 2021-01-27 CY CY20211100067T patent/CY1124363T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301322I2 (nl) | Repotrectinib en/of farmaceutisch aanvaardbare zouten daarvan | |
| DK3717471T3 (da) | Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme | |
| DK3259253T3 (da) | Sulfonylureaer og relaterede forbindelser og brug af samme | |
| DK3102575T3 (da) | Nye salte og farmaceutiske sammensætninger deraf til behandlingen af inflammatoriske lidelser | |
| DK3140310T3 (da) | Syntese af boronatsalte og brug deraf | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| DK3429998T3 (da) | Fremgangsmåde til fremstilling af quinolin-2-yl-phenylaminderivater og disses salte | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3278803T3 (da) | Fast farmaceutisk doseringsform af PARP-inhibitor, og anvendelse af fast farmaceutisk doseringsform af PARP-inhibitor | |
| DK3099800T3 (da) | Ekspression og oprensning af crm197 og beslægtede proteiner | |
| DK3484469T3 (da) | Sammensætninger og fremgangsmåder til potentiering af antimikrober | |
| DK3215493T3 (da) | Syntese af copanlisib og dihydrochloridsalt deraf | |
| HUE055242T2 (hu) | Omecamtiv mecarbil szintézise | |
| DK4335517T3 (da) | Indgivelse og dosering af diaminofenothiaziner | |
| DK3204398T3 (da) | Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer | |
| DK3592337T3 (da) | Farmaceutiske formuleringer af phloroglucinol og trimethylphloroglucinol | |
| DK3340973T3 (da) | Farmaceutisk acceptable salte af beta-guanidinopropionsyre med forbedrede egenskaber og anvendelser deraf | |
| DK3448846T3 (da) | Syntese af indazoler | |
| DK3263565T3 (da) | Cyklisk aminderivat og farmaceutisk anvendelse deraf | |
| DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner | |
| DK3349775T3 (da) | Fastfase-peptidsyntesefremgangsmåder og tilhørende systemer | |
| DK3389669T3 (da) | Triterpensaponinvarianter, syntesefremgangsmåder og anvendelse deraf | |
| DK3448849T3 (da) | Syntese af indazoler | |
| DK3347006T3 (da) | Deutererede analoger af etifoxin, derivater deraf og anvendelser deraf |